Millennium Management
OBIO icon

Millennium Management’s Orchestra BioMed OBIO Stock Holding History

Millennium Management’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-702,543
Closed -$2.99M – 6249
2026
Q1 		$2.99M Buy
702,543
+459,070
+189% +$1.95M ﹤0.01% 3469
2025
Q4 		$1.01M Sell
243,473
-130,514
-35% -$527K ﹤0.01% 4486
2025
Q3 		$927K Sell
373,987
-35,687
-9% -$98.5K ﹤0.01% 4686
2025
Q2 		$1.1M Buy
+409,674
New +$1.2M ﹤0.01% 4338
2025
Q1 		– Sell
-21,513
Closed -$86.1K – 6246
2024
Q4 		$86.1K Buy
+21,513
New +$116K ﹤0.01% 5500
2023
Q3 		– Sell
-54,057
Closed -$378K – 6421
2023
Q2 		$378K Buy
+54,057
New +$820K ﹤0.01% 4737
2022
Q3 		– Sell
-254,466
Closed -$2.53M – 7371
2022
Q2 		$2.53M Buy
254,466
+194,867
+327% +$1.94M ﹤0.01% 3458
2022
Q1 		$591K Sell
59,599
-60,371
-50% -$596K ﹤0.01% 4996
2021
Q4 		$1.21M Buy
119,970
+22,940
+24% +$226K ﹤0.01% 4238
2021
Q3 		$960K Buy
97,030
+34,004
+54% +$336K ﹤0.01% 4736
2021
Q2 		$643K Buy
63,026
+35,000
+125% +$362K ﹤0.01% 5079
2021
Q1 		$314K Hold
28,026
– – ﹤0.01% 5183
2020
Q4 		$359K Sell
28,026
-14,837
-35% -$169K ﹤0.01% 4436
2020
Q3 		$471K Buy
+42,863
New +$481K ﹤0.01% 3614

Other funds holding OBIO

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Millennium Management's OBIO Position: Q2 2026 in Review

Millennium Management sold out of Orchestra BioMed (OBIO) in Q2 2026, closing a stake of 702,543 shares — an estimated $2.99M sold.

Millennium Management first reported a position in OBIO in Q3 2020 and held it in 14 quarters. The position peaked at $2.99M in Q1 2026. 77 funds tracked by Wall St. Rank hold OBIO as of Q2 2026.

  • Millennium Management reported no remaining Orchestra BioMed position as of Q2 2026 after selling out during the quarter.
  • Millennium Management sold 702,543 Orchestra BioMed shares in Q2 2026, an estimated $2.99M.
  • Millennium Management first reported a position in Orchestra BioMed in Q3 2020 and held it in 14 quarters.
  • Millennium Management's Orchestra BioMed position peaked at $2.99M in Q1 2026.
  • 77 funds tracked by Wall St. Rank held Orchestra BioMed as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.